Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

The Role of ADAMTS13 Activity Levels on Disease Exacerbation or Relapse in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura: Post Hoc Analysis of the Phase 3 HERCULES and Post-HERCULES Studies

Johanna A. Kremer Hovinga Strebel, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knoebl, Flora Peyvandi, Spero Cataland, PAUL Coppo, Umer Khan, Laurel A. Menapace, Ana Paula Marques, Sriya Gunawardena, Marie Scully

Blood (2022) 140 (Supplement 1): 5651–5653.

https://doi.org/10.1182/blood-2022-156306

Published: 2022

Journal Articles

Neonatal Exchange Transfusion: When Should We Think about Hereditary Thrombotic Thrombocytopenic Purpura (hTTP)?

Erika Tarasco, Kenneth D. Friedman, James N. George, Paul Knöbl, Ingrid Hrachovinova, Masanori Matsumoto, Reinhard Schneppenheim, Anne Sophie Von Krogh, Bernhard Lammle, Johanna A. Kremer Hovinga Strebel

Blood (2022) 140 (Supplement 1): 336–337.

https://doi.org/10.1182/blood-2022-168612

Published: 2022

Journal Articles

A Role of Immunothrombosis in Acquired Antibody-Mediated Thrombophilia's: Classical Complement and Neutrophil Activation in APS and HIT

Annina Capraru, Tiphaine Ruggeri, Noelia Schärz, Laura Delvasto-Nunez, Justine Brodard, Gerard van Mierlo, Johanna A. Kremer Hovinga Strebel, Anne Angelillo-Scherrer, Ilse Jongerius, Sacha Sergio Zeerleder

Blood (2022) 140 (Supplement 1): 8368–8370.

https://doi.org/10.1182/blood-2022-164592

Published: 2022

Journal Articles

Long-Term Safety and Efficacy of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura (aTTP): The Post-HERCULES Study

Marie Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knoebl, Flora Peyvandi, Spero Cataland, Paul Coppo, Johanna A. Kremer Hovinga Strebel, Jessica Minkue Mi Edou, Rui de Passos Sousa, Filip Callewaert, Sriya Gunawardena, Julie Lin

Blood (2021) 138 (Supplement 1): 2080.

https://doi.org/10.1182/blood-2021-148839

Published: 2021

Journal Articles

Prevalence of Stroke and Cognitive Impairment in Patients with Hereditary Thrombotic Thrombocytopenic Purpura

Azra Borogovac, Erika Tarasco, Johanna A. Kremer Hovinga Strebel, Kenneth D. Friedman, Adam S. Asch, Sara K. Vesely, Calin I. Prodan, James N. George

Blood (2021) 138 (Supplement 1): 1008.

https://doi.org/10.1182/blood-2021-148714

Published: 2021

Journal Articles

Long-Term Renal Outcomes in Hereditary TTP Patients: Data from the International Hereditary TTP Registry

Erika Tarasco, Ralph Wendt, Anne Sophie von Krogh, Sibylle Tschumi, James N. George, Masanori Matsumoto, Paul Knöbl, Reinhard Schneppenheim, Bernhard Lämmle, other members of Hereditary TTP Registry Steering Committee, Johanna A. Kremer Hovinga Strebel

Blood (2021) 138 (Supplement 1): 770.

https://doi.org/10.1182/blood-2021-146128

Published: 2021

Journal Articles

Genotype-Phenotype Correlation in Congenital TTP: New Insights from a Multicentre Study with 121 Patients

Anette Anette Van Dorland, PhD, Magnus Mansouri Taleghani, MD, Kenneth Dale Friedman, MD, James George, MD, Ingrid Hrachovinova, PhD, Paul Knöbl, MD PhD, Bernhard Lammle, MD, Masanori Matsumoto, MD, Anne Sophie von Krogh, MD, Reinhard Schneppenheim, MDPhD, Isabella Aebi-Huber, Bütikofer Lukas, PhD, Zuzana Cermakova, PhD, Petter Quist-Paulsen, MD PhD, Deirdra Terrell, PhD, Sara K. Vesely, PhD MPH, Yoshihiro Fujimura, MD PhD, Johanna A. Kremer Hovinga Strebel, MD

Blood (2018) 132 (Supplement 1): 376.

https://doi.org/10.1182/blood-2018-99-112095

Published: 2018

Journal Articles

Profiling the Autoantibody Repertoire of Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Patients By Single Cell Sorting and Deep Sequencing of Splenic B-Cells

Magdalena Skowronska, PhDstudent, Monica M Schaller, Asst Prof, PhD, Johanna A. Kremer Hovinga Strebel, Prof, MD

Blood (2015) 126 (23): 108.

https://doi.org/10.1182/blood.V126.23.108.108

Published: 2015

Journal Articles

Anti-Idiotypic-Designed-Ankyrin-Repeat-Molecules (DARPins) Universally Neutralize Plasma-Derived Autoantibodies in Acquired TTP Patients

Monica M Schaller, Asst Prof, PhD, Monique Vogel, PhD, Magdalena Skowronska, PhDstudent, Irmela Sulzer, Johanna A. Kremer Hovinga Strebel, Prof, MD

Blood (2015) 126 (23): 104.

https://doi.org/10.1182/blood.V126.23.104.104

Published: 2015

Journal Articles

Unexpected High Frequency of Upshaw-Schulman Syndrome in Norway

Anne-Sophie von Krogh, MD, Anders Waage, MD, PhD, Johanna A. Kremer Hovinga Strebel, MD, Petter Quist-Paulsen, MD, PhD

Blood (2012) 120 (21): 3315.

https://doi.org/10.1182/blood.V120.21.3315.3315

Published: 2012

Journal Articles

International Registry for Patients with Hereditary Thrombotic Thrombocytopenic Purpura (TTP) – Upshaw-Schulman Syndrome

Magnus Mansouri Taleghani, Yoshihiro Fujimura, MD, PhD, James N. George, MD, Ingrid Hrachovinova, PhD, Paul Knoebl, MD, Bernhard Lämmle, MD, Petter Quist-Paulsen, MD, PhD, Reinhard Schneppenheim, MD, PhD, Johanna A. Kremer Hovinga Strebel, MD

Blood (2012) 120 (21): 4654.

https://doi.org/10.1182/blood.V120.21.4654.4654

Published: 2012

Journal Articles

Long-Term Outcomes of Renal Function in Patients with TTP Associated with Severe ADAMTS13 Deficiency

Jessica A Reese, MS, Cassandra C Deford, BA, Zayd Al-Nouri, MD, MPH, Deirdra Terrell, PhD, Sara K. Vesely, PhD, MPH, Johanna A. Kremer Hovinga Strebel, MD, Bernhard Lammle, James N. George, MD

Blood (2011) 118 (21): 2215.

https://doi.org/10.1182/blood.V118.21.2215.2215

Published: 2011

Journal Articles

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy in Acquired TTP Is the Expression of a General Dysregulation of the Immune Response,

Monica Schaller, PhD, Irmela Sulzer, Magnus Mansouri, MD student, Bernhard Lämmle, MD, Johanna A. Kremer Hovinga Strebel, MD

Blood (2011) 118 (21): 3299.

https://doi.org/10.1182/blood.V118.21.3299.3299

Published: 2011

Journal Articles

Inhibitory Spleen-Derived Anti-ADAMTS13 Antibodies Are Characterized by a Limited Number of Variable Heavy Chain CDR3 Signatures in Patients with Relapsing Acquired Thrombotic Thromobocytopenic Purpura

Monica Schaller, PhD, Gianna Tanno, Irmela Sulzer, Monique Vogel, PhD, Karim Kentouche, MD, Bernhard Laemmle, MD, Johanna A. Kremer Hovinga Strebel, MD

Blood (2011) 118 (21): 194.

https://doi.org/10.1182/blood.V118.21.194.194

Published: 2011

Journal Articles

Restricted Immunglobulin Gene Usage of Spleen-Derived Specific Anti-ADAMTS13 B-Cells In Relapsing TTP Treated with or without Rituximab.

Monica M. Schaller Tschan, PhD, Karin Sprecher, Master, Irmela Sulzer, technician, Monique Vogel, PhD, Beda Stadler, Prof, Karim Kentouche, MD, Bernhard Lämmle, Prof, Johanna A. Kremer Hovinga Strebel, MD

Blood (2010) 116 (21): 1431.

https://doi.org/10.1182/blood.V116.21.1431.1431

Published: 2010

Journal Articles

Are Patients Who Have Recovered From ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP) at Risk for Developing Systemic Lupus Erythematosus (SLE)?

Deirdra R. Terrell, PhD, Zayd Al-Nouri, Judith A. James, MD, PhD, Johanna A. Kremer Hovinga Strebel, MD, Bernhard Lämmle, MD, Sara K. Vesely, PhD, MPH, James N. George, MD

Blood (2010) 116 (21): 2519.

https://doi.org/10.1182/blood.V116.21.2519.2519

Published: 2010

NARROW

The Role of ADAMTS13 Activity Levels on Disease Exacerbation or Relapse in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura: Post Hoc Analysis of the Phase 3 HERCULES and Post-HERCULES Studies

Neonatal Exchange Transfusion: When Should We Think about Hereditary Thrombotic Thrombocytopenic Purpura (hTTP)?

A Role of Immunothrombosis in Acquired Antibody-Mediated Thrombophilia's: Classical Complement and Neutrophil Activation in APS and HIT

Long-Term Safety and Efficacy of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura (aTTP): The Post-HERCULES Study

Prevalence of Stroke and Cognitive Impairment in Patients with Hereditary Thrombotic Thrombocytopenic Purpura

Long-Term Renal Outcomes in Hereditary TTP Patients: Data from the International Hereditary TTP Registry

Genotype-Phenotype Correlation in Congenital TTP: New Insights from a Multicentre Study with 121 Patients

Profiling the Autoantibody Repertoire of Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Patients By Single Cell Sorting and Deep Sequencing of Splenic B-Cells

Anti-Idiotypic-Designed-Ankyrin-Repeat-Molecules (DARPins) Universally Neutralize Plasma-Derived Autoantibodies in Acquired TTP Patients

Unexpected High Frequency of Upshaw-Schulman Syndrome in Norway

International Registry for Patients with Hereditary Thrombotic Thrombocytopenic Purpura (TTP) – Upshaw-Schulman Syndrome

Long-Term Outcomes of Renal Function in Patients with TTP Associated with Severe ADAMTS13 Deficiency

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy in Acquired TTP Is the Expression of a General Dysregulation of the Immune Response,

Inhibitory Spleen-Derived Anti-ADAMTS13 Antibodies Are Characterized by a Limited Number of Variable Heavy Chain CDR3 Signatures in Patients with Relapsing Acquired Thrombotic Thromobocytopenic Purpura

Restricted Immunglobulin Gene Usage of Spleen-Derived Specific Anti-ADAMTS13 B-Cells In Relapsing TTP Treated with or without Rituximab.

Are Patients Who Have Recovered From ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP) at Risk for Developing Systemic Lupus Erythematosus (SLE)?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only